- Home
- CBAT vs ALGS Comparison
CBAT vs ALGS Comparison
Compare CBAT & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBAT
- ALGS
- Stock Information
- Founded
- CBAT 1999
- ALGS 2018
- Country
- CBAT China
- ALGS United States
- Employees
- CBAT N/A
- ALGS N/A
- Industry
- CBAT Industrial Machinery/Components
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- CBAT Miscellaneous
- ALGS Health Care
- Exchange
- CBAT Nasdaq
- ALGS Nasdaq
- Market Cap
- CBAT 90.4M
- ALGS 72.6M
- IPO Year
- CBAT N/A
- ALGS 2020
- Fundamental
- Price
- CBAT $0.92
- ALGS $9.32
- Analyst Decision
- CBAT
- ALGS Strong Buy
- Analyst Count
- CBAT 0
- ALGS 2
- Target Price
- CBAT N/A
- ALGS $60.00
- AVG Volume (30 Days)
- CBAT 635.2K
- ALGS 97.2K
- Earning Date
- CBAT 11-18-2025
- ALGS 11-06-2025
- Dividend Yield
- CBAT N/A
- ALGS N/A
- EPS Growth
- CBAT N/A
- ALGS N/A
- EPS
- CBAT N/A
- ALGS N/A
- Revenue
- CBAT $145,462,366.00
- ALGS $3,174,000.00
- Revenue This Year
- CBAT N/A
- ALGS N/A
- Revenue Next Year
- CBAT $60.02
- ALGS N/A
- P/E Ratio
- CBAT N/A
- ALGS N/A
- Revenue Growth
- CBAT N/A
- ALGS N/A
- 52 Week Low
- CBAT $0.57
- ALGS $3.76
- 52 Week High
- CBAT $1.28
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- CBAT 44.49
- ALGS 43.57
- Support Level
- CBAT $0.93
- ALGS $9.25
- Resistance Level
- CBAT $1.00
- ALGS $10.89
- Average True Range (ATR)
- CBAT 0.10
- ALGS 0.79
- MACD
- CBAT -0.01
- ALGS -0.07
- Stochastic Oscillator
- CBAT 7.14
- ALGS 13.76
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.